The Public Offer of Withdrawal, opened from Wednesday November 30, 2022 to Friday December 30, 2022 has been closed.
This Takeover Bid, which aims at acquiring 174,239 shares of the company Adwya, is initiated by the company “Laboratoires Teriak SA”, holding in concert with the company “Kilani Pharmaceuticals Holding” and Messrs Lassaad and Rafik Kilani, 21,353,761 shares. The latter represent 99.19% of the voting rights of the company ADWYA, out of the 21,528,000 shares making up the registered capital of the company Adwya.
Out of the 174,239 shares, subject of the Takeover Bid, 75,147 shares were acquired by MAC SA, a stock exchange brorker, for the benefit of the company “Laboratoires Teriak SA”, initiator of the Takeover Bid.
The Adwya Company securities will therefore be delisted from the Main Market of capital securities of the Stock Exchange and transferred to the Over-the-Counter (OTC) Market, as from January 5, 2023, date from which the Adwya security will be negotiable on the Over-the-Counter Market, in accordance with the provisions of article 76 new of the General Rules of the Stock Exchange.
